	Natural Compounds as Nephroprotective Agents: Therapeutic Potential Against Drug-Induced Kidney Injury. J Biochem Mol Toxicol Shyam M, Pal A, Dey D, J K, Sharma V, Wadhwa J, Srirangan P, Prince SE. PMID: 41420444 [PubMed - indexed for MEDLINE]
	Interconnected Organs: Exploring the Impact of Kidney-Lung Crosstalk in Critically Ill Neonates and Children. Compr Physiol Starr MC, Gorga S, Gist KM. PMID: 41420276 [PubMed - indexed for MEDLINE]
	Novel DNA methylation biomarkers in urine for non-invasive diagnosis of bladder urothelial carcinoma. Clin Epigenetics Shi C, Xu J, Chen Q, Gao X, Chen L, Jin C, Yu Z, Dou X. PMID: 41420251 [PubMed - indexed for MEDLINE]
	Amino acid metabolism in diabetic kidney disease. Clin Exp Nephrol Mise K. PMID: 41420104 [PubMed - as supplied by publisher]
	Association of hemoglobin glycation index with the severity and mortality of cardiovascular-kidney-metabolic syndrome: a population-based cohort study. Cardiovasc Diabetol Endocrinol Rep Geng L, Diao X, Yu HJ, Xu A. PMID: 41419979 [PubMed]
	Associations of inflammation-related hematological profile with the early-stages of cardiovascular-kidney-metabolic syndrome and the mediating role of body composition: evidence from the China National Health Survey. Diabetol Metab Syndr Huang L, Lin B, Mu Y, Ren Y, Li Q, Li Y, Ma Y, Fan Y, Zhu G, Song Z, Xia Y. PMID: 41419970 [PubMed - as supplied by publisher]
	Discovery and validation of RAB3B as a diagnostic biomarker for prostate cancer with serum PSA below 10 ng/mL based on a multi-omics study. Cancer Cell Int Zhao C, Deng G, Chen J, Li H, Fan R, Fu Z, Ye D, Lai C, Di J. PMID: 41419883 [PubMed - as supplied by publisher]
	Construction and verification of a prognostic model for prostate cancer based on ribosome biogenesis-related genes. BMC Med Genomics Xie J, Tang Y, Wang Y, Gao X, Fu F, Liu Y, Yi C, Zhou G, Wang Z, Chen C, Jin P, Cai Y, Zhou J. PMID: 41419859 [PubMed - indexed for MEDLINE]
	Comparative study of ureteral access sheath versus suction access sheath in retrograde intrarenal surgery. BMC Urol Chiang TY, Lee KH, Hsieh CC, Chen ZH, Huang SK, Chiu AW. PMID: 41419842 [PubMed - indexed for MEDLINE]
	Transperineal cognitive fusion MRI-targeted biopsy shows higher detection rates than systematic biopsy in prostate cancer: a prospective cohort study. BMC Urol Jiang J, Wang K, Xie X, Mo X, Fu Z, Wang Q, Qian F. PMID: 41419822 [PubMed - as supplied by publisher]
	The impact of socio-economic disparities on kidney transplant outcomes: insights from a monocentric Italian study. Updates Surg Lai Q, Melandro F, Poli L, Piazzolla M, Della Pietra F, Zullino V, Diamantini G, Brisciani M, Quaresima S, Rossi M, Pugliese F, Garofalo M. PMID: 41419726 [PubMed - as supplied by publisher]
	Risk factors for enterococcal bacteraemia in urology: a multicentre cohort study. Eur J Clin Microbiol Infect Dis Roger PM, Ferre A, Abram B, Normand G, Tondut L, Tanneau Y, Beaujon N, Valizadeh A, Turcan V, Malaterre J, Lay F, Strzelecki AC, Boumezber S, Girard D, Savoie PH, Alenda O, Assi A. PMID: 41419629 [PubMed - as supplied by publisher]
	Quality of Life After Parathyroidectomy in Chronic Kidney Disease-Related Hyperparathyroidism: A Systematic Review and Meta-Analysis. World J Surg Alves Filho W, D'Elboux Guimarães Brescia M, Magnabosco FF, Catafesta das Neves M, Arap SS, Santos RO, de Almeida Mota Ramalho J, Luiz de Menezes Montenegro F, Studart da Fonseca MR. PMID: 41419434 [PubMed - as supplied by publisher]
	Predictive Value of Prior Non-muscle-invasive Bladder Cancer for the Effectiveness of Neoadjuvant Chemotherapy in Localized Muscle-invasive Bladder Cancer: A Real-world Analysis of the BLADRAC Cohort. Eur Urol Oncol Grobet-Jeandin E, Diamant E, Gabriel PE, De Olivera A, Harber T, Colombel M, Hanquiez P, Chatain V, Vordos D, Duquesne I, Borz MB, Verhoest G, De Varennes AM, Surlemont L, Ghenassia M, Masson-Lecomte A, Peyrottes A, Lebacle C, Beniac P, Léon P, Larré S, Taha F, Marcq G, Szostek A, Pradere B, Calleris G, Xylinas E, Allory Y, Bajeot AS, Prost D, Audenet F, Thibault C, Rouprêt M, Roumiguié M, Seisen T. PMID: 41419411 [PubMed - as supplied by publisher]
	Exercise During or After Intravesical Therapy for Bladder Cancer: A Randomized Feasibility Trial. Semin Oncol Nurs Arthuso FZ, Fairey AS, Boulé NG, Jacobsen NE, Dean LW, Courneya KS. PMID: 41419398 [PubMed - as supplied by publisher]
	Therapy strategies to defeat prostate cancer heterogeneity. Semin Nucl Med Jadvar H, Iravani A. PMID: 41419380 [PubMed - as supplied by publisher]
	Strategies to Mitigate Breast-related Adverse Events in Patients with High-risk Biochemically Recurrent Prostate Cancer Receiving Enzalutamide Monotherapy: Perspectives and Challenges. Eur Urol Focus Shore ND, Freedland SJ, Horvath LG, O'Sullivan JM, Giorgi U, Ray EC, Ross AE, Tang Y, Russell D, Iwata KK, Rosales M, Ganguli A, Tombal B. PMID: 41419364 [PubMed - as supplied by publisher]
	Prognostic Factors of Trimodal Therapy for Muscle-invasive Bladder Cancer: A Systematic Review and Meta-analysis. Eur Urol Focus Miyajima K, Matsukawa A, Yanagisawa T, Miszczyk M, Roessler N, Inoue S, Nishimura S, Alqahtani AS, Alfarhan AR, Urabe F, Mori K, Karakiewicz PI, Reis LO, Kimura T, Shariat SF. PMID: 41419363 [PubMed - as supplied by publisher]
	Antidiabetic Medications and Bladder Cancer Risk in Type 2 Diabetes: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Endocr Pract Rao Y, Meng S, Yi-Wen Yu E, Chen Y, van Alebeek R, Al-Zalabani AH, Zeegers MP, Wesselius A. PMID: 41419174 [PubMed - as supplied by publisher]
	Navigating the winding road toward precision prostate cancer care. Gene Rahman S, Arun AS, Kim IY, Oh WK, Kim JW, Kim WJ. PMID: 41419150 [PubMed - as supplied by publisher]

Articles 1 - 20 / 462330

Page 1 of 23117



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy